Thus, to address the role of Th17 cells in sepsis-induced mortality in CD43-/- hosts, we neutralized the activity of Th17 cells in CD43-/- during sepsis by administering an anti-IL-17 mAb on days 0, 2, 4, and 6 post-CLP. This evidence concerns the gene IL17A and Sepsis.